Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leuprolide for Ovarian Preservation After HCT
NCT01343368Phase 2Terminated
- Sponsor
- Masonic Cancer Center
- Start
- Jul 2011
- Primary completion
- Apr 2015
- Countries
- 1
01
Overview
A Phase 2 trial of leuprolide in primary ovarian insufficiency (POI), sponsored by Masonic Cancer Center. Started Jul 2011; status: terminated.
02
Drugs
leuprolide
03
Conditions
primary ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT01343368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01343368.